What is CNV Sequencing?

Copy Number Variation (CNV) Sequencing is a genome-wide approach for identifying changes in DNA copy number, including genomic deletions and duplications. These structural variations can range from a few kilobases to several megabases in size and represent an important source of genetic diversity. CNVs are widely studied for their association with developmental biology, inherited disorders, cancer genomics, reproductive genetics, and complex disease research.

Our CNV Sequencing Service utilizes Low-Pass Whole Genome Sequencing (Low-Pass WGS) to detect copy number alterations across the entire genome in a cost-effective and scalable manner. Rather than generating deep sequencing coverage, this approach sequences the genome at low coverage—typically between 0.1× and 5×—providing sufficient genomic information for accurate copy number analysis while significantly reducing sequencing costs.

Following sequencing, advanced bioinformatics pipelines evaluate read-depth patterns across thousands of genomic regions. Areas exhibiting consistently increased sequencing depth may indicate copy number gains (duplications), whereas regions with reduced read depth may represent copy number losses (deletions). Statistical modeling and quality-controlled analytical workflows are then applied to identify and characterize genome-wide CNVs with high confidence.

Compared with targeted assays, Low-Pass WGS offers comprehensive genome-wide coverage without being restricted to predefined genomic loci. This enables researchers to investigate both large and smaller copy number alterations across diverse study populations, making it an effective solution for research involving prenatal genomics, reproductive health, oncology, rare genetic disorders, population genetics, and other structural genomics applications.

Why Choose CNV Sequencing over Microarrays?

While Chromosomal Microarray Analysis (CMA) has historically been the standard for CNV detection, it is limited by fixed probe design and lower throughput. Low-Pass WGS has emerged as the superior alternative, offering higher resolution and unbiased genome-wide coverage at a comparable or lower cost.

Key Advantages of Low-Pass Whole Genome Sequencing (Low-Pass WGS)

Our Low-Pass WGS-based CNV analysis combines comprehensive genome-wide coverage with advanced bioinformatics to deliver reliable structural variant detection for a wide range of research applications.

• High Detection Performance

Low-Pass WGS enables the reliable identification of large copy number variations and many medium-sized genomic alterations across the genome. Its genome-wide sequencing approach enhances the ability to detect structural variants that may be difficult to identify using targeted array-based technologies.

• Cost-Efficient Genome-Wide Analysis

By utilizing low sequencing coverage, this approach significantly reduces sequencing costs while maintaining high analytical value for CNV studies. It provides an economical solution for large-scale research projects without compromising genome-wide coverage.

• Improved Genomic Resolution

Unlike hybridization-based methods that rely on predefined probes, Low-Pass WGS evaluates sequencing data across the entire genome. This enables more accurate localization of copy number changes, improved breakpoint characterization, and enhanced confidence in CNV identification.

• Scalable for High-Throughput Studies

Our optimized laboratory and bioinformatics workflows support projects ranging from small pilot studies to large population-scale research programs. Standardized processing ensures consistent, reproducible results across hundreds or thousands of samples.

• Comprehensive Genome Coverage

Whole-genome sequencing provides unbiased assessment of genomic copy number changes without being restricted to predefined genomic regions. This broad coverage allows researchers to investigate known and potentially novel CNVs across diverse sample types and study populations.

• Flexible Applications Across Multiple Research Areas

Low-Pass WGS is suitable for a broad range of genomics research, including prenatal and reproductive genetics, cancer genomics, rare disease research, population genetics, constitutional genomics, and structural variant discovery.

Applications of CNV Sequencing

Copy Number Variation (CNV) Sequencing is widely utilized across genomics research to identify structural genomic alterations that contribute to biological variation and disease mechanisms. Its genome-wide analytical capability makes it a valuable tool for a broad range of research and translational applications.

• Genetic Disorder Research

CNV Sequencing enables the identification of genomic deletions and duplications associated with inherited and developmental conditions. It supports research into neurodevelopmental disorders, intellectual disabilities, congenital anomalies, and other genetic diseases by providing detailed insights into structural genomic variation.

• Prenatal and Reproductive Genetics

Low-Pass WGS-based CNV analysis is extensively used in prenatal and reproductive genomics research to investigate chromosomal copy number changes. It facilitates the detection of genomic imbalances that may contribute to developmental abnormalities and supports studies focused on fetal genetics and reproductive health.

• Cancer Genomics

CNV analysis plays an important role in oncology research by identifying copy number alterations within tumor genomes. Researchers can investigate genomic amplifications, deletions, and other structural changes affecting cancer-related genes, helping to better understand tumor development, progression, molecular heterogeneity, and therapeutic response.

• Pharmacogenomics Research

Copy number variations in genes involved in drug metabolism and transport can influence biological responses to therapeutic compounds. CNV Sequencing supports pharmacogenomics research by enabling the characterization of these genomic changes, contributing to studies of drug response, toxicity, and precision medicine.

• Infectious Disease and Microbial Genomics

CNV Sequencing can be applied to microbial genomics research to investigate genomic variation among bacterial, viral, and fungal organisms. These analyses support studies of microbial evolution, pathogenicity, antimicrobial resistance, and host–pathogen interactions.

• Population and Evolutionary Genomics

Genome-wide CNV profiling enables researchers to examine structural genetic diversity across populations. This application is valuable for studies of population genetics, evolutionary biology, biodiversity, and the identification of genomic regions associated with adaptation and natural selection.

• Rare Disease and Structural Variant Research

Comprehensive CNV detection helps researchers investigate structural genomic variants that may contribute to rare and complex diseases. Genome-wide analysis enables the discovery and characterization of clinically relevant copy number changes, supporting biomarker discovery and expanding our understanding of disease-associated genomic variation.

• Biomarker Discovery and Translational Research

CNV data can be integrated with other genomic and molecular datasets to identify potential biomarkers for research and translational studies. This supports investigations into disease mechanisms, molecular classification, therapeutic target identification, and precision medicine initiatives.

CNV Sequencing Workflow

At N2Jenomics Lab Pvt. Ltd., every CNV Sequencing project follows a standardized workflow designed to ensure high-quality data generation, accurate analysis, and reliable results. From sample assessment to final bioinformatics reporting, each stage is performed under stringent quality control protocols.

Step 1: Sample Quality Assessment

All submitted samples undergo comprehensive quality evaluation to verify DNA concentration, purity, and integrity before library preparation. This ensures that only high-quality samples proceed to sequencing, maximizing data reliability and analytical accuracy.

Step 2: Library Preparation

Qualified DNA samples are processed using optimized library preparation protocols that include DNA fragmentation, end repair, adapter ligation, and sample indexing. Libraries are subjected to additional quality checks to confirm their suitability for sequencing.

Step 3: High-Throughput Sequencing

Validated libraries are sequenced on advanced Illumina® sequencing platforms using paired-end 150 bp (PE150) chemistry. This approach generates high-quality genome-wide sequencing data suitable for comprehensive copy number variation (CNV) analysis.

Step 4: Bioinformatics Analysis

Sequencing data are processed through a robust bioinformatics workflow that includes quality filtering, read alignment to the reference genome, read-depth normalization, CNV detection, genomic annotation, and quality assessment. The final results are compiled into detailed reports with graphical visualizations and supporting data files to facilitate downstream research and interpretation.

CNV Sequencing Bioinformatics Analysis

At N2Jenomics Lab Pvt. Ltd., we provide comprehensive bioinformatics solutions that transform raw sequencing data into meaningful genomic insights. Our standardized analytical workflows combine advanced computational methods with rigorous quality control to deliver accurate, reproducible, and research-ready CNV results. In addition to our standard pipeline, we also offer customized analyses tailored to specific research objectives.

CNV Detection

• Overview:
Following sequence alignment, read-depth information is extracted from processed BAM files and analyzed across the genome using statistically defined genomic intervals.

• Objective:
To identify genomic regions exhibiting copy number gains or losses by detecting significant deviations in sequencing read depth.

• Analytical Approach:
Validated CNV detection algorithms, including CNVnator and equivalent computational methods, are employed to generate high-confidence CNV candidates.

• Deliverables:

• - Genome-wide CNV detection results
• - Preliminary list of copy number gains and losses
• - Quality metrics supporting CNV identification

CNV Filtering and Functional Annotation

• Overview:
Detected CNVs undergo multiple quality-control and filtering steps to eliminate low-confidence events. High-confidence variants are subsequently annotated using genomic databases and reference annotations.

• Objective:
To improve result accuracy while providing biological context for each identified structural variant.

• Analytical Tools:
Our workflow incorporates widely accepted bioinformatics tools, including BEDTools, AnnotSV, and other annotation resources.

• Deliverables:

• - High-confidence annotated CNV dataset
• - Gene and genomic feature annotations
• - Functional and positional information for downstream interpretation

Data Validation and Visualization

• Overview:
All high-confidence CNVs are independently reviewed using visualization and validation workflows to ensure analytical consistency and biological relevance.

• Objective:
To verify detected copy number alterations through graphical assessment of sequencing coverage, genomic location, and supporting evidence.

• Analytical Tools:
Visualization platforms such as Integrative Genomics Viewer (IGV), CNVnator, and R-based visualization tools are used to generate publication-quality figures and quality assessment plots.

• Deliverables:

• - CNV validation visualizations
• - Genome-wide copy number profiles
• - Publication-ready graphical representations
• - Quality assessment reports

• Customized Bioinformatics Services

Every research project has unique analytical requirements. In addition to our standard CNV analysis pipeline, we provide customized bioinformatics solutions tailored to specific study designs, experimental objectives, and downstream analyses. Whether your research involves human, animal, plant, or microbial genomes, our bioinformatics specialists work closely with you to develop analytical strategies that deliver accurate, reproducible, and biologically meaningful results.

Sample Requirements

• All DNA samples must undergo purity and concentration testing to ensure sequencing quality.
• If you have questions regarding sample preparation or require a custom plan, feel free to contact us anytime for expert assistance.

Why Choose N2Jenomics Lab Pvt. Ltd. for CNV Sequencing?

At N2Jenomics Lab Pvt. Ltd., we combine advanced Low-Pass Whole Genome Sequencing (Low-Pass WGS) with robust bioinformatics to deliver accurate, scalable, and research-focused CNV analysis. Our integrated workflow is designed to generate high-quality genomic data that supports a wide range of applications, from basic research to translational and clinical research studies.

• Comprehensive Genome-Wide CNV Analysis

Our optimized Low-Pass WGS workflow enables reliable detection of copy number variations across the entire genome. By integrating advanced sequencing technologies with validated computational pipelines, we provide comprehensive structural variant analysis to support studies in genetics, oncology, reproductive genomics, neuroscience, and other life science disciplines.

• Advanced Bioinformatics and Data Interpretation

Accurate variant detection is only the first step. Our experienced bioinformatics team applies rigorous quality control, functional annotation, and data interpretation workflows to transform sequencing results into meaningful biological insights. Detailed reports, genome-wide visualizations, and customizable analytical outputs facilitate downstream research and scientific publication.

• Reliable and Efficient Workflow

Our standardized laboratory procedures and automated analytical pipelines ensure consistent data quality, rapid project execution, and reproducible results. From sample processing through final reporting, every project follows stringent quality assurance practices designed to maximize analytical confidence.

• High-Resolution Structural Variant Detection

Our workflow is optimized to identify a broad spectrum of copy number alterations, including large chromosomal gains and losses, sub-chromosomal deletions and duplications, and other structural genomic changes. The achievable detection resolution depends on factors such as sequencing depth, sample quality, genome complexity, and study design, allowing flexible solutions for diverse research applications.

• Scalable and Cost-Effective Solutions

Whether your project involves a small pilot study or a large population-scale cohort, our high-throughput sequencing infrastructure supports efficient processing of samples at competitive pricing. Our scalable workflow enables researchers to generate comprehensive genome-wide CNV data while maintaining excellent cost efficiency.

• Personalized Scientific Collaboration

We believe every research project deserves dedicated attention. Our team of genomics scientists and bioinformatics experts works closely with clients throughout the project lifecycle, providing consultation on experimental design, sample requirements, data analysis, result interpretation, and downstream applications. We are committed to supporting your research from initial planning to final data delivery.

• Commitment to Research Excellence

By combining advanced sequencing technology, robust analytical pipelines, comprehensive quality control, and responsive scientific support, N2Jenomics Lab Pvt. Ltd. delivers dependable CNV sequencing solutions that help researchers generate accurate, reproducible, and publication-ready genomic data with confidence.

1. How does CNV Sequencing identify copy number variations using next-generation sequencing (NGS)?

CNV Sequencing combines next-generation sequencing (NGS) with advanced bioinformatics algorithms to identify genomic regions that have gained or lost DNA copies. The analytical workflow generally includes the following stages:

• DNA Library Preparation
Genomic DNA is fragmented and converted into sequencing libraries suitable for high-throughput sequencing.

• Sequence Alignment
The generated sequencing reads are aligned to a reference genome, allowing read coverage to be measured across the entire genome.

• Genome-Wide Read Depth Analysis
The genome is divided into multiple genomic intervals (bins), and sequencing depth is calculated for each region. Areas with consistently increased read depth may indicate copy number gains (duplications), while reduced read depth may suggest copy number losses (deletions).

• Statistical Analysis and CNV Calling
Advanced computational algorithms evaluate read-depth patterns while correcting for technical variation and sequencing bias. High-confidence CNVs are then identified, filtered, and annotated for downstream biological interpretation.

2. What are the limitations of CNV Sequencing?

Like any genomic technology, CNV Sequencing has certain technical considerations that should be taken into account during study design and data interpretation.

• Sequencing Depth Influences Resolution

The ability to detect smaller copy number changes depends on sequencing coverage. Increasing sequencing depth generally improves the sensitivity and resolution of CNV detection, particularly for small genomic alterations.

• Bioinformatics Requirements

Accurate CNV analysis relies on sophisticated computational pipelines and experienced bioinformatics expertise. High-performance computing resources and validated analytical workflows are essential for reliable genome-wide variant detection.

• Complex Genomic Regions

Highly repetitive sequences, segmental duplications, GC-rich regions, and areas with low sequence complexity can present analytical challenges. Advanced filtering and quality-control procedures are used to improve confidence in detected variants.

3. How is CNV Sequencing used to study complex diseases such as cancer and neurodevelopmental disorders?

CNV Sequencing is widely used in genomics research to investigate structural genomic alterations that may contribute to disease biology. Common research applications include:

• Cancer Genomics

Genome-wide CNV analysis enables researchers to identify genomic amplifications and deletions affecting cancer-associated genes. These structural alterations provide valuable insights into tumor biology, molecular subtypes, disease progression, and therapeutic research.

• Neurodevelopmental Research

CNV Sequencing supports investigations into genomic variations associated with neurodevelopmental conditions, including autism spectrum disorders, intellectual disabilities, and other developmental disorders. These studies help researchers better understand the genetic mechanisms underlying neurological development.

• Disease Mechanism and Biomarker Discovery

Comparing CNV profiles between healthy and affected populations allows researchers to identify structural variants associated with disease susceptibility, biological pathways, and molecular function. These findings contribute to biomarker discovery and translational genomics research.

• Precision Medicine Research

CNV analysis helps characterize genomic differences that may influence biological responses to therapeutic interventions. This information supports pharmacogenomics studies, therapeutic target discovery, and precision medicine research in preclinical and translational settings.